(Q36815277)

16 August 2017

1 reference

title

Overactive bladder pharmacotherapy: what does the future hold? (English)

1 reference

16 August 2017

0 references

Roger R Dmochowski

1

1 reference

16 August 2017

publication date

1 June 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

99 Suppl 3

1 reference

16 August 2017

page(s)

13-16

1 reference

Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06697.X

Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06697.X

Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06697.X

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06697.X

Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06697.X

Systemic capsaicin treatment impairs the micturition reflex in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06697.X

Effects of spinal cord injury on neurofilament immunoreactivity and capsaicin sensitivity in rat dorsal root ganglion neurons innervating the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06697.X

Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06697.X

10.1111/J.1464-410X.2007.06697.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference